Yalla Group Ltd
F:80Q
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Yalla Group Ltd
F:80Q
|
AE |
|
Brainstorm Cell Therapeutics Inc
OTC:BCLI
|
US |
|
Loandepot Inc
F:LDD
|
US |
|
B
|
Beyond Inc
XMUN:OVER
|
US |
|
K
|
Kalbe Farma Tbk PT
XMUN:LCLA
|
ID |
|
Sensus Healthcare Inc
F:5TX
|
US |
|
O
|
ONWARD Medical NV
F:63E
|
NL |
Shareholder Yield
Current shareholder yield for 
80Q is
hidden
.
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
80Q Price
Yalla Group Ltd
| Average Annual Return | 7.9% |
| Standard Deviation of Annual Returns | 50.74% |
| Max Drawdown | -42% |
| Market Capitalization | 812.2m EUR |
| Shares Outstanding | 158 870 000 |
| Percentage of Shares Shorted |
N/A
|
